Heike U. Peulen

Eindhoven, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

ESTRO recommendations for the use, planning and delivery of reirradiation in locally recurrent rectal cancer - Endorsed by ASTRO.

ESTRO recommendations for the use, planning and delivery of reirradiation in locally recurrent rectal cancer - Endorsed by ASTRO.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 08, 2026

Evolution of Prognosis and Management in Curative Treatment of Locally Recurrent Rectal Cancer: A Comprehensive Analysis from 2000 to 2023.

Evolution of Prognosis and Management in Curative Treatment of Locally Recurrent Rectal Cancer: A Comprehensive Analysis from 2000 to 2023.

Journal: Annals of surgical oncology

Published: May 12, 2026

Current clinical practice of radiotherapy for the non-operative treatment of patients with unresectable locally recurrent rectal cancer: results of a national survey of the dutch society for radiotherapy and oncology.

Current clinical practice of radiotherapy for the non-operative treatment of patients with unresectable locally recurrent rectal cancer: results of a national survey of the dutch society for radiotherapy and oncology.

Journal: Radiation oncology (London, England)

Published: April 17, 2026

Automated annotation error detection and correction for manual two-dimensional cinematic magnetic resonance imaging segmentations using segment anything 2.

Automated annotation error detection and correction for manual two-dimensional cinematic magnetic resonance imaging segmentations using segment anything 2.

Journal: Physics and imaging in radiation oncology

Published: March 17, 2026

A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial.

A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial.

Journal: BMC cancer

Published: March 16, 2026

ASO Visual Abstract: Locally Recurrent Rectal Cancer in the Lateral Compartment: Imaging Features and Association with Primary Tumor Characteristics.

ASO Visual Abstract: Locally Recurrent Rectal Cancer in the Lateral Compartment: Imaging Features and Association with Primary Tumor Characteristics.

Journal: Annals of surgical oncology

Published: March 04, 2026

Short-term quality of life after metastases-directed SBRT: Results of the ESTRO & EORTC OligoCare cohort.

Short-term quality of life after metastases-directed SBRT: Results of the ESTRO & EORTC OligoCare cohort.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 03, 2026

Local control in oligometastatic cancer patients following metastasis-directed stereotactic ablative radiotherapy: An interim analysis of ESTRO EORTC E2-RADIatE OligoCare cohort.

Local control in oligometastatic cancer patients following metastasis-directed stereotactic ablative radiotherapy: An interim analysis of ESTRO EORTC E2-RADIatE OligoCare cohort.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 27, 2026

The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysis.

The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 24, 2026

Simultaneous concurrent chemoradiation and SBRT in stage III NSCLC: Safety report of the phase I hybrid trial.

Simultaneous concurrent chemoradiation and SBRT in stage III NSCLC: Safety report of the phase I hybrid trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 18, 2026

Simultaneous concurrent chemoradiation and SBRT in stage III NSCLC: Safety report of the phase I hybrid trial.

Simultaneous concurrent chemoradiation and SBRT in stage III NSCLC: Safety report of the phase I hybrid trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 18, 2026

ASO Author Reflections: Characteristics of Locally Recurrent Rectal Cancer in the Lateral Compartment.

ASO Author Reflections: Characteristics of Locally Recurrent Rectal Cancer in the Lateral Compartment.

Journal: Annals of surgical oncology

Published: January 22, 2026

Showing 1-12 of 61

Last Updated: 09/26/2026